EP
CLX icon

Eudaimonia Partners’s Clorox CLX Stock Holding History

Eudaimonia Partners’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.25M Sell
8,140
-28
-0.3% -$4.18K 0.3% 76
2023
Q4 		$1.16M Buy
8,168
+3,048
+60% +$406K 0.3% 71
2023
Q3 		$671K Sell
5,120
-277
-5% -$42.1K 0.16% 138
2023
Q2 		$858K Buy
5,397
+3,808
+240% +$614K 0.19% 124
2023
Q1 		$251K Sell
1,589
-168
-10% -$25.2K 0.06% 284
2022
Q4 		$247K Sell
1,757
-883
-33% -$125K 0.06% 289
2022
Q3 		$339K Sell
2,640
-2,404
-48% -$347K 0.09% 218
2022
Q2 		$711K Buy
5,044
+262
+5% +$37.4K 0.13% 175
2022
Q1 		$665K Buy
+4,782
New +$733K 0.11% 205
2021
Q3 		$737K Sell
4,450
-777
-15% -$134K 0.13% 180
2021
Q2 		$940K Buy
5,227
+42
+0.8% +$7.67K 0.18% 144
2021
Q1 		$1M Sell
5,185
-149
-3% -$28.7K 0.21% 118
2020
Q4 		$1.08M Buy
5,334
+41
+0.8% +$8.48K 0.24% 102
2020
Q3 		$1.11M Sell
5,293
-997
-16% -$222K 0.29% 90
2020
Q2 		$1.38M Buy
6,290
+585
+10% +$117K 0.52% 48
2020
Q1 		$988K Buy
5,705
+941
+20% +$155K 0.43% 61
2019
Q4 		$731K Buy
+4,764
New +$712K 0.29% 94

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Eudaimonia Partners's CLX Position: Q1 2024 in Review

Eudaimonia Partners reduced its Clorox (CLX) stake by 0.34% in Q1 2024, selling an estimated $4.18K and leaving 8,140 shares worth $1.25M. The position accounts for 0.3% of the portfolio, ranked #76.

Eudaimonia Partners first reported a position in CLX in Q4 2019 and has held it in 17 quarters since. The position peaked at $1.38M in Q2 2020. 1,143 funds tracked by Wall St. Rank hold CLX as of Q1 2024.

  • Eudaimonia Partners held 8,140 shares of Clorox worth $1.25M as of Q1 2024.
  • Eudaimonia Partners sold 28 Clorox shares in Q1 2024, an estimated $4.18K.
  • Clorox made up 0.3% of Eudaimonia Partners's portfolio in Q1 2024, its #76 holding.
  • Eudaimonia Partners first reported a position in Clorox in Q4 2019 and has held it in 17 quarters since.
  • Eudaimonia Partners's Clorox position peaked at $1.38M in Q2 2020.
  • 1,143 funds tracked by Wall St. Rank held Clorox as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.